스피드 바카라 Biologics to exhibit at BIO USA 2025, marking 13 years of participation with a ‘dedicated booth’

[by Yu, Suin] 스피드 바카라 Biologics announced on June 9 that it will participate in the '2025 BIO International Convention (BIO USA),' the world's largest exhibition in the biotechnology and pharmaceutical industry.

BIO USA is an event organized by the Biotechnology Innovation Organization (BIO) in the U.S., held annually in June across major biotechnology clusters in the country. The event is recognized as a key venue for international networking, where professionals from the biotech and pharmaceutical industries convene to explore potential partnerships.

This year's event will take place over four days, from June 16 to 19 (local time), at the Boston Convention & Exhibition Center in Massachusetts, USA. Themed 'The World Can't Wait,' the convention is expected to attract over 20,000 industry professionals from around the world.

Since its establishment in 2011, 스피드 바카라 Biologics has consistently participated in the event for 13 consecutive years, making it the sole Korean company to operate a 'single booth' throughout this period and highlighting its strong global order competitiveness. At this year’s event, the company will establish a 167 m2 booth at the entrance of the exhibition hall, an area with the highest foot traffic, to attract the attention of attendees.

Notably, to highlight the company's expanding contract development and manufacturing (CDMO) capabilities and new facilities and services, 스피드 바카라 Biologics will showcase advanced features such as an LED wall and interactive touch screens. These installations aim to dynamically present various content and reinforce the brand’s image of future innovation by emphasizing the application of digital technology, a topic of significant interest in the biotechnology and pharmaceutical industries today.

The booth will introduce 스피드 바카라 Biologics’ recent advancements and its vision to become a ‘global top-tier CDMO.’ Highlights include the world’s highest biopharmaceutical production capacity (CAPA) of 784,000 liters, achieved with the recent launch of Plant 5, along with capabilities in the development and production of multi-specific antibodies to quickly meet evolving customer needs. The booth will also present the expanded CDMO portfolio, which now includes a new antibody-drug conjugate (ADC) service introduced this year, and the company’s digital transformation (DT) initiatives, such as AI-based operations. Through these efforts, 스피드 바카라 Biologics aims to promote its competitive strengths and actively seek collaborations in various fields.

Additionally, promotional banners will be strategically placed in key areas of the exhibition venue, like the sky bridge visible from the entrance and the stairs leading to the main event hall, ensuring visibility to event participants from virtually any location. Through diverse content and these strategic placements, the company plans to expand its contact points with existing global customers while attracting new clients. This effort seeks to increase brand awareness and market share in the global CDMO market, particularly in the United States.